Shanghai Gopherwood Biotech Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shanghai Gopherwood Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer (NCT05715398) | Shanghai Gopherwood Biotech Co., Ltd. | 2023-02-01 |
| Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors (NCT05505877) | Shanghai Gopherwood Biotech Co., Ltd. | 2022-09-10 |
Track Shanghai Gopherwood Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.